$13.71+0.22 (+1.63%)
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.
InfuSystem Holdings, Inc. in the Healthcare sector is trading at $13.71 with a market capitalization of $238M. Wall Street consensus targets $16.83 (3 analysts), implying a +22.8% move over the next 12 months. The stock is currently near its 52-week high of $13.85, remaining 36.8% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $36.93Mβ | $33.68Mβ | $36.23Mβ | $36.49Mβ | $36.00M |
| Gross Profit | $21.41Mβ | $19.68Mβ | $20.43Mβ | $20.82Mβ | $19.87M |
| Operating Income | $4.15Mβ | $1.59Mβ | $3.71Mβ | $3.81Mβ | $3.78M |
| Net Income | $3.23Mβ | $1.02Mβ | $2.04Mβ | $2.26Mβ | $2.60M |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic a...